wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41192354-F94B4222-D8C9-40CA-87BF-1D220AEEDED9
Q41192354-F94B4222-D8C9-40CA-87BF-1D220AEEDED9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41192354-F94B4222-D8C9-40CA-87BF-1D220AEEDED9
Combination of 5α-reductase inhibitor with combined androgen blockade (CAB) as a novel cytoreductive regimen before prostate brachytherapy: Ultra-CAB.
P2860
Q41192354-F94B4222-D8C9-40CA-87BF-1D220AEEDED9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41192354-F94B4222-D8C9-40CA-87BF-1D220AEEDED9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
24d32e5cf4006464cb90b87322ba219184f8d131
P2860
Potent increased risk of the initiation of DNA replication in human prostate cancer with the use of 5α-reductase inhibitors.